After the IPO last week, Windlas Biotech is all set to finalize the allotment of its shares to all the applicant investors on 11th August. The company is one of the top brands in terms of revenue in the domestic pharma formulations contact development.
The IPO of the pharma giant was subscribed 22.47 per cent and received a positive response from investors. The company was able to channel Rs 401.53 crores through the issue.
The company plans to utilize the raised capital for expansion of capacity at its Dehradun plant and for fulfilling its working capital requirements. As per the company’s Draft Red Herring Prospectus, the company is set to finalize the allotment of shares today on 11th August.
Pioneer in Investment Advisor
*Inclusive of complaints of previous years resolved in the current month/year.
#Inclusive of complaints pending as on last day of the year.
^Average Resolution time is the sum total of time taken to resolve each complaint in days, in the current month divided by total number of complaints resolved in the current month.
Data is updated on or before 7th of every month.
**ATR submission date has been considered as the date of resolution of the complaint by IA-CapitalVia.